您好,欢迎来到试剂仪器网! [登录] [免费注册]
试剂仪器网
位置:首页 > 产品库 > N-Octadecyl-N'-propyl-sulfamide
立即咨询
咨询类型:
     
*姓名:
*电话:
*单位:
Email:
*留言内容:
请详细说明您的需求。
*验证码:
 
N-Octadecyl-N'-propyl-sulfamide
本产品不向个人销售,仅用作科学研究,不用于任何人体实验及非科研性质的动物实验。
N-Octadecyl-N'-propyl-sulfamide图片
CAS NO:925891-74-3
规格:98%
分子量:390.7
包装与价格:
包装价格(元)
5mg电议
10mg电议
25mg电议
50mg电议

产品介绍
activator of PPARα
CAS:925891-74-3
分子式:C21H46N2O2S
分子量:390.7
纯度:98%
存储:Store at -20°C

Background:

N-Octadecyl-N'-propyl-sulfamide is a potent activator of PPARα with EC50 value of 100 nM [1].


Peroxisome proliferator-activated receptors (PPARs) are members of a superfamily of nuclear hormone receptors with three isoforms PPARα, PPARγ and PPARδ. These ligand-activated transcription factors play important roles in the regulation of lipid and glucose metabolism, and are interesting targets useful in diseases related to altered metabolism such as diabetes, dyslipidemia and obesity [1].


N-Octadecyl-N'-propyl-sulfamide, an analog of oleoylethanolamide (OEA), is a potent hypolipidemic compound and a potent feeding suppressant. N-Octadecyl-N'-propyl-sulfamide is a concentration-dependent activator of PPARα with EC50 value of 100 nM. In MCF-7 cells transfected with human PPARα, N-Octadecyl-N'-propyl-sulfamide exhibited potent and selective PPARα subtype transactivation activity [1][2].


In 24-h food-deprived Wistar rats, i.p. injection of N-Octadecyl-N'-propyl-sulfamide (1 mg/kg) reduced body weight and produced a marked reduction in plasma triglycerides, which were similar to the effects of OEA. In genetically obese Zucker (fa/fa) rats, i.p. injection of N-Octadecyl-N'-propyl-sulfamide (1 mg/kg) reduced body weight gain and food intake [1].


参考文献:
[1].  Cano C, Pavón J, Serrano A, et al. Novel sulfamide analogs of oleoylethanolamide showing in vivo satiety inducing actions and PPARalpha activation. J Med Chem. 2007 Jan 25;50(2):389-93.
[2].  Fu J1, Gaetani S, Oveisi F, et al. Oleylethanolamide regulates feeding and body weight through activation of the nuclear receptor PPAR-alpha. Nature. 2003 Sep 4;425(6953):90-3.